These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 8491256

  • 1. The individual enantiomers of cis-cromakalim possess K+ channel opening activity.
    Quast U, Villhauer EB.
    Eur J Pharmacol; 1993 Apr 15; 245(2):165-71. PubMed ID: 8491256
    [Abstract] [Full Text] [Related]

  • 2. Effects of rubidium on responses to potassium channel openers in rat isolated aorta.
    Greenwood IA, Weston AH.
    Br J Pharmacol; 1993 Aug 15; 109(4):925-32. PubMed ID: 8401946
    [Abstract] [Full Text] [Related]

  • 3. The effects of racemic cromakalim, BRL 38226 and levcromakalim on the membrane potential of the rat aorta and of BRL 38226 on the contractile activity of the rat aorta and portal vein.
    Bishop BE, Doggrell SA.
    J Auton Pharmacol; 1994 Apr 15; 14(2):99-108. PubMed ID: 8051202
    [Abstract] [Full Text] [Related]

  • 4. Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.
    Perez-Vizcaino F, Casis O, Rodriguez R, Gomez LA, Garcia Rafanell J, Tamargo J.
    Br J Pharmacol; 1993 Nov 15; 110(3):1165-71. PubMed ID: 8298804
    [Abstract] [Full Text] [Related]

  • 5. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
    Quast U, Bray KM, Andres H, Manley PW, Baumlin Y, Dosogne J.
    Mol Pharmacol; 1993 Mar 15; 43(3):474-81. PubMed ID: 8450836
    [Abstract] [Full Text] [Related]

  • 6. Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aorta.
    Uchida W, Hirano Y, Shirai Y, Taguchi T, Masuda N, Shibasaki K, Hirano S, Matsumoto Y, Tsuzuki R, Yanagisawa I.
    Arch Int Pharmacodyn Ther; 1994 Mar 15; 327(3):330-43. PubMed ID: 7848015
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U, Cook NS.
    J Pharmacol Exp Ther; 1989 Jul 15; 250(1):261-71. PubMed ID: 2501478
    [Abstract] [Full Text] [Related]

  • 8. Some degree of overlap exists between the K(+)-channels opened by cromakalim and those opened by minoxidil sulphate in rat isolated aorta.
    Bray K, Quast U.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep 15; 344(3):351-9. PubMed ID: 1961260
    [Abstract] [Full Text] [Related]

  • 9. Ba2+ differentially inhibits the Rb+ efflux promoting and the vasorelaxant effects of levcromakalim and minoxidil sulfate in rat isolated aorta.
    Quast U, Baumlin Y, Loffler C.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec 15; 353(1):86-93. PubMed ID: 8750921
    [Abstract] [Full Text] [Related]

  • 10. The dualistic mode of action of the vasodilator drug, nicorandil, differentiated by glibenclamide in 86Rb flux studies in rabbit isolated vascular smooth muscle.
    Kreye VA, Lenz T, Theiss U.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan 15; 343(1):70-5. PubMed ID: 1827659
    [Abstract] [Full Text] [Related]

  • 11. Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery.
    Masuzawa K, Matsuda T, Asano M.
    Br J Pharmacol; 1990 May 15; 100(1):143-9. PubMed ID: 2115387
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of the K(+)-channel openers cromakalim and minoxidil sulphate on vascular smooth muscle.
    Wickenden AD, Grimwood S, Grant TL, Todd MH.
    Br J Pharmacol; 1991 May 15; 103(1):1148-52. PubMed ID: 1878752
    [Abstract] [Full Text] [Related]

  • 13. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
    Masuzawa K, Asano M, Matsuda T, Imaizumi Y, Watanabe M.
    J Pharmacol Exp Ther; 1990 May 15; 253(2):586-93. PubMed ID: 2160002
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K, Barras M, Zazzi-Sudriez E, Martin DJ, Armstrong JM, Hicks PE.
    Br J Pharmacol; 1992 Sep 15; 107(1):58-65. PubMed ID: 1422579
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of KRN2391, a novel vasodilator, compared with those of cromakalim, pinacidil and nifedipine in rat aorta.
    Kashiwabara T, Nakajima S, Izawa T, Fukushima H, Nishikori K.
    Eur J Pharmacol; 1991 Apr 10; 196(1):1-7. PubMed ID: 1678711
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Potentiation of P1075-induced K+ channel opening by stimulation of adenylate cyclase in rat isolated aorta.
    Linde C, Quast U.
    Br J Pharmacol; 1995 Jun 10; 115(3):515-21. PubMed ID: 7582466
    [Abstract] [Full Text] [Related]

  • 20. Effects of the K+ channel blocker tedisamil on 86Rb efflux induced by cromakalim, high potassium and noradrenaline, and on mechanical tension in rabbit isolated vascular smooth muscle.
    Kreye VA, Pfründer D, Theiss U.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb 10; 345(2):238-43. PubMed ID: 1570026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.